Cross Country Healthcare, Inc. (CCRN) Earnings History
Annual and quarterly earnings data from 1999 to 2024
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 20.4% | -1.3% | -1.1% |
| 2023 | 22.3% | 5.6% | 3.6% |
| 2022 | 22.3% | 9.6% | 6.6% |
| 2021 | 22.4% | 8.3% | 7.9% |
| 2020 | 24.2% | -1.1% | -1.5% |
Download Data
Export CCRN earnings history in CSV or JSON format
Free sign-in required to download data
Cross Country Healthcare, Inc. (CCRN) Earnings Overview
As of March 2, 2026, Cross Country Healthcare, Inc. (CCRN) reported trailing twelve-month net income of -$16M, reflecting -1.2% year-over-year growth. The company earned $-0.48 per diluted share over the past four quarters, with a net profit margin of -0.0%.
Looking at the long-term picture, CCRN's historical earnings data spans multiple years. The company achieved its highest annual net income of $186M in fiscal 2022.
Cross Country Healthcare, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to industry peers including SOLV ($1.56B net income, 0.2% margin), HCSG ($40M net income, 0.0% margin), AMN (-$96M net income, -0.0% margin), CCRN has room to improve margins relative to the peer group. Compare CCRN vs SOLV →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
26 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$15M | -120.0% | -$17M | $-0.44 | -1.1% | -1.3% |
| 2023 | $73M | -60.9% | $113M | $2.05 | 3.6% | 5.6% |
| 2022 | $186M | +40.9% | $270M | $5.02 | 6.6% | 9.6% |
| 2021 | $132M | +1118.4% | $139M | $3.53 | 7.9% | 8.3% |
| 2020 | -$13M | +77.5% | -$9M | $-0.34 | -1.5% | -1.1% |
| 2019 | -$58M | -240.5% | -$16M | $-1.56 | -7.0% | -1.9% |
| 2018 | -$17M | -145.2% | -$13M | $-0.48 | -2.1% | -1.6% |
| 2017 | $38M | +370.9% | $12M | $1.01 | 4.3% | 1.4% |
| 2016 | $8M | +80.3% | $6M | $0.15 | 1.0% | 0.7% |
| 2015 | $4M | +113.9% | $21M | $0.14 | 0.6% | 2.7% |
See CCRN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CCRN Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare CCRN vs AGIO
See how CCRN stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is CCRN growing earnings?
CCRN EPS of $-0.48 reflects slowing growth at -1.2%, below the 5-year CAGR of N/A. TTM net income is $-16M. Expansion rate has moderated.
What are CCRN's profit margins?
Cross Country Healthcare, Inc. net margin is -0.0%, with operating margin at -0.0%. Below-average margins reflect competitive or cost pressures.
How consistent are CCRN's earnings?
CCRN earnings data spans 1999-2024. The current earnings trend is -1.2% YoY. Historical data enables comparison across business cycles.